Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayant Sharad Vaidya

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|August 30, 2003
Passive smoking: study was flawed from outsetJayant Sharad Vaidya
JAMA Oncology|August 14, 2020
Targeted Intraoperative Radiotherapy for Early Breast Cancer-ReplyJayant Sharad Vaidya, Max Bulsara, Michael Baum
Frontiers in Oncology|August 29, 2022
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systemsJayant Sharad Vaidya, Uma Jayant Vaidya, Michael Baum, et al.
Frontiers in Oncology|October 18, 2024
Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer instituteLorenzo Vinante, Jayant Sharad Vaidya, Angela Caroli, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|August 30, 2003
Passive smoking: study was flawed from outsetJayant Sharad Vaidya
JAMA Oncology|August 14, 2020
Targeted Intraoperative Radiotherapy for Early Breast Cancer-ReplyJayant Sharad Vaidya, Max Bulsara, Michael Baum
Frontiers in Oncology|August 29, 2022
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systemsJayant Sharad Vaidya, Uma Jayant Vaidya, Michael Baum, et al.
Frontiers in Oncology|October 18, 2024
Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer instituteLorenzo Vinante, Jayant Sharad Vaidya, Angela Caroli, et al.
Pageof 1